Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Syndesi Therapeutics

Syndesi Therapeutics is a company developing molecules for the treatment of cognitive disorders of various neurological conditions.

Overview Structured Data Issues Contributors Activity

syndesitherapeutics.com

Is a

Company

Organization

Company attributes

Industry

Biomedical engineering

Location

B2X

Founder

Legal Name

Syndesi Therapeutics SA

Number of Employees (Ranges)

11 – 50

Email Address

info@syndesitherapeutics.com

Full Address

Chemin du Cyclotron 6, Louvain-la-Neuve, Walloon Region 1348, BE

Investors

VIVES (venture capital)

S.R.I.W.

Novo Seeds

Fountain Healthcare Partners

Johnson & Johnson Innovation – JJDC

V-Bio Ventures

‌

SRIW

Founded Date

2017

Total Funding Amount (USD)

20,800,000

Latest Funding Round Date

February 2018

Latest Funding Type

Series A

Country

Belgium

Other attributes

Company Operating Status

Active

Public/Private

Public

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Syndesi Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API